NEW YORK, Dec. 4, 2014 /PRNewswire/ --
Avanir Pharmaceuticals, Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Avanir Pharmaceuticals, Inc. ("AVNR") to Otsuka Pharmaceutical
Co., Ltd. in an all-cash transaction valued at approximately
$3.5 billion or $17 per share.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Carbonite, Inc.
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties in connection with the
unsolicited proposal from J2 Global, Inc. to acquire Carbonite,
Inc. ("CARB") for $15.00 per share in
cash.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Casey's General Stores, Inc.
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of Casey's
General Stores, Inc. ("CASY"). Specifically, on November 24, 2014, CASY discovered a $30 million error in its income taxes related to
tax credits on ethanol that is blended into gasoline and will
revise its financial statements.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Nymox Pharmaceutical Corporation
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of Nymox
Pharmaceutical Corporation ("NYMX"). Specifically, on
November 3, 2014, NYMX announced that
two phase 3 studies of its prostate enlargement treatment failed to
produce the desired results.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Puma Biotechnology Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties by the board of Puma Biotechnology
Inc. ("PBYI"). Specifically, on December 2, 2014, PBYI announced its PB272 drug
application will be delayed from first half 2015 to first quarter
2016 and that the application will seek to approve the drug to
treat early-stage breast cancer instead of metastatic breast
cancer.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
RealD Inc.
Lifshitz & Miller announces an investigation into
possible breaches of fiduciary duties by the board of RealD Inc.
("RLD"). Specifically, on November 3,
2014, RLD announced that it rejected an unsolicited
$12-a-share takeover bid from
Starboard Value LP.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Spansion, Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Spansion, Inc. ("CODE") to Cypress Semiconductor Corp. in an
all-stock transaction valued at approximately $4 billion.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2014 Lifshitz &
Miller. The law firm responsible for this advertisement is
Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)
493-9780. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-avanir-pharmaceuticals-inc-carbonite-inc-caseys-general-stores-inc-nymox-pharmaceutical-corporation-puma-biotechnology-inc-reald-inc-and-spansion-inc-300005090.html
SOURCE Lifshitz & Miller Law Firm